Pharma facility managers should look for a contamination mat supplier that holds relevant quality certifications, demonstrates measurable contaminant capture performance, offers reusable and antimicrobial solutions, and provides genuine consultative support throughout the process. In a regulated industry where contamination control is a compliance requirement, the supplier you choose directly affects your audit readiness and operational integrity. The questions below address each of the key criteria worth evaluating before making a decision.
What certifications should a contamination mat supplier hold?
A contamination mat supplier serving pharmaceutical facilities should hold, at minimum, ISO 9001 certification for quality management systems and ISO 14001 certification for environmental management. These certifications confirm that the supplier’s manufacturing processes are audited, consistent, and aligned with internationally recognised standards — which matters when your own facility is subject to GMP, FDA, or regulatory inspection.
Beyond ISO standards, look for compliance with chemical safety regulations such as California Proposition 65 and EU REACH. These confirm that the materials used in the mats have been assessed for hazardous substances, which is a non-negotiable consideration in pharmaceutical and cleanroom environments where material compatibility is scrutinised closely.
Certification is not just a box-ticking exercise. It signals that the supplier can provide documentation to support your internal validation processes and external audits. When a regulatory inspector asks how your contamination control products are qualified, your supplier’s certifications become part of your answer.
How do reusable contamination mats compare to disposable sticky mats?
Reusable contamination mats offer significantly better long-term performance and value than disposable sticky mats. While peel-off sticky mats appear cost-effective at purchase, they lose adhesion quickly, require frequent replacement, and generate substantial single-use plastic waste. Reusable polymeric mats, by contrast, maintain consistent performance over a lifespan of three to five years and are washable and re-deployable without degrading capture efficiency.
The operational comparison is equally important. Disposable mats create recurring procurement cycles, waste disposal costs, and the risk of inconsistent coverage when mats run low or are not replaced on schedule. Reusable mats eliminate this variability. Once installed, they deliver predictable, validated performance at every entry point.
From a sustainability perspective, reusable mats are a meaningfully better option. Reducing reliance on single-use plastic is increasingly relevant for pharmaceutical organisations with ESG commitments or supplier sustainability requirements. Total cost of ownership, when calculated across a three to five year period, consistently favours reusable solutions over their disposable counterparts.
What contaminant capture performance should pharma mats achieve?
Pharmaceutical facility hygiene mats should be capable of capturing up to 99.9% of shoe and wheel-borne contaminants at the point of entry. This level of performance is the benchmark for critical contamination control, particularly at cleanroom entrances, gowning rooms, and airlocks where particulate ingress poses the greatest compliance risk.
Performance should be validated, not assumed. Ask any supplier for evidence of their capture efficiency data. Mats that have been independently tested or whose performance claims are supported by documented methodology give you a defensible position during regulatory audits. Vague claims about contamination reduction without supporting data should be treated with caution.
It is also worth considering the traffic type the mat is designed to handle. Pedestrian entry points require different mat specifications than areas used by forklifts, pallet trucks, or large carts. A supplier that offers purpose-built solutions for different traffic zones will provide more reliable performance than one offering a single generic product across all use cases. Reviewing the full contamination control mat range available from your supplier is a practical starting point for matching product to environment.
Should pharma facilities choose antimicrobial mats for cleanrooms?
Yes. Pharmaceutical facilities should choose mats with built-in antimicrobial protection for cleanroom and controlled environment applications. Standard mats capture particulates but do not inhibit microbial growth on the mat surface itself. In environments where microbial contamination is a validated risk, an antimicrobial mat provides an additional layer of protection that a non-treated surface cannot.
Built-in antimicrobial technology works continuously, reducing the risk of the mat itself becoming a source of contamination between cleaning cycles. This is particularly relevant in high-frequency entry points where mats are contacted repeatedly throughout a shift. The antimicrobial protection should be integrated into the material rather than applied as a surface coating, which can degrade with washing and wear.
For pharmaceutical cleanrooms operating under GMP guidelines, the ability to demonstrate that contamination control measures are proactive rather than reactive is a meaningful compliance advantage. Antimicrobial facility hygiene mats contribute to that position in a way that standard mats do not.
What support should a contamination control supplier provide?
A reliable contamination control supplier should provide consultative support from initial assessment through to installation and ongoing service — not simply fulfil a product order. For pharma facility managers, this means access to specialists who understand cleanroom design, regulatory requirements, and the practical realities of managing controlled environments at scale.
At minimum, expect the following from a credible supplier:
- A site survey or consultation to assess entry points, traffic types, and contamination risk zones
- Product recommendations matched to specific facility needs rather than generic off-the-shelf suggestions
- Documentation to support internal validation and audit requirements
- Guidance on mat maintenance, cleaning protocols, and performance monitoring
- Responsive account support throughout the product lifespan
Suppliers who offer a free site survey before any purchase commitment demonstrate confidence in their solution and respect for your evaluation process. This kind of consultative approach is particularly valuable in pharmaceutical settings where the wrong product selection can have compliance consequences.
How can pharma managers evaluate a supplier’s sustainability credentials?
Pharma managers should evaluate a supplier’s sustainability credentials by looking beyond marketing language and examining concrete commitments, product design choices, and regulatory compliance. The most meaningful indicators are whether the supplier’s products reduce single-use waste, whether they hold environmental management certifications, and whether they have published measurable sustainability targets.
Key questions to ask a prospective supplier include:
- Do your products reduce or replace single-use plastic alternatives?
- Are your manufacturing processes certified to ISO 14001?
- Do you have a published carbon reduction target with a defined timeline?
- Are your products compliant with EU REACH and other chemical safety regulations?
- What is the expected product lifespan, and how does this affect total waste output?
A reusable mat with a three to five year lifespan and washable construction is inherently a more sustainable choice than disposable alternatives that require constant replacement and disposal. For pharmaceutical organisations with ESG reporting obligations or supply chain sustainability requirements, this distinction matters both operationally and commercially.
How Dycem helps pharma facilities meet contamination control requirements
Dycem is the world’s original manufacturer of reusable contamination control mats, with over 60 years of expertise supporting pharmaceutical, healthcare, and precision manufacturing environments. For facility managers navigating compliance pressure, audit requirements, and the limitations of legacy hygiene solutions, Dycem provides a validated, consultative alternative.
Here is what Dycem offers pharma facilities specifically:
- Up to 99.9% contaminant capture at shoe and wheel level, validated across pedestrian and wheeled traffic zones
- Built-in Biomaster antimicrobial protection integrated into every mat, not applied as a surface treatment
- ISO 9001 and ISO 14001 certified manufacturing, with compliance to EU REACH and California Proposition 65
- A full product range including CleanZone for cleanroom entrances, WorkZone for heavy-wheeled traffic, and Floating Mats for flexible or temporary zones
- A three to five year product lifespan, reducing single-use plastic waste and total cost of ownership compared to disposable sticky mats
- Free site surveys and specialist consultation to match the right solution to your facility’s specific entry points and risk profile
If you are reviewing your current contamination control approach or preparing for a regulatory audit, speak to a Dycem specialist to arrange a free site survey and find out which solution is right for your facility.